alendronate has been researched along with Myalgia in 1 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
Myalgia: Painful sensation in the muscles.
Excerpt | Relevance | Reference |
---|---|---|
"A total of 140 postmenopausal women or men aged older than 50 years who met the indications for osteoporosis treatment were randomized to receive either generic (Bonmax®) or brand alendronate (Fosamax®) 70 mg/week over a 12-month period during the May 2014 to June 2015 study period." | 9.24 | Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment. ( Jarusriwanna, A; Songcharoen, P; Unnanuntana, A, 2017) |
"A total of 140 postmenopausal women or men aged older than 50 years who met the indications for osteoporosis treatment were randomized to receive either generic (Bonmax®) or brand alendronate (Fosamax®) 70 mg/week over a 12-month period during the May 2014 to June 2015 study period." | 5.24 | Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment. ( Jarusriwanna, A; Songcharoen, P; Unnanuntana, A, 2017) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Unnanuntana, A | 1 |
Jarusriwanna, A | 1 |
Songcharoen, P | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Randomized Trial Comparing Efficacy and Safety of Brand Versus Generic Alendronate for Osteoporosis Treatment[NCT02371252] | Phase 4 | 140 participants (Actual) | Interventional | 2014-04-30 | Completed | ||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
Percent changes of bone mineral density at lumbar spine (L1-L4) from baseline to 1-year after treatment will be compared and analysed between 2 groups. (NCT02371252)
Timeframe: 1 year after treatment
Intervention | percent (Mean) |
---|---|
Original Alendronate (Fosamax) | 5.54 |
Generic Alendronate (Bonmax) | 5.39 |
Percent changes of bone mineral density at total hip from baseline to 1-year after treatment will be compared and analysed between 2 groups. (NCT02371252)
Timeframe: 1 year after treatment
Intervention | percent (Mean) |
---|---|
Original Alendronate (Fosamax) | 2.48 |
Generic Alendronate (Bonmax) | 2.52 |
1 trial available for alendronate and Myalgia
Article | Year |
---|---|
Randomized clinical trial comparing efficacy and safety of brand versus generic alendronate (Bonmax®) for osteoporosis treatment.
Topics: Absorptiometry, Photon; Aged; Aged, 80 and over; Alendronate; Arthralgia; Bone Density; Bone Density | 2017 |